3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Infections
3
Prostatic Neoplasms
2
Pancreatic Cyst
2
Breast Neoplasms
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Staphylococcal Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neoplasms
1
Multiple Myeloma
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Leukemia, B-Cell
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Interventions
ofatumumab
10
Rituximab
6
ibrutinib
5
Cyclophosphamide
5
fludarabine phosphate
4
Bendamustine Hydrochloride
4
fludarabine
3
Lenalidomide
3
Alemtuzumab
3
spebrutinib
2
navitoclax
2
acalabrutinib
2
KW-2478
2
venetoclax
1
tirabrutinib
1
obinutuzumab
1
idelalisib
1
dinaciclib
1
Tablets
1
Stem Cell Transplantation
1
Rabeprazole
1
Pentostatin
1
Metronidazole
1
Methylprednisolone
1
Magnetic Resonance Imaging
1
MLN 8237
1
Leukapheresis
1
Lansoprazole
1
Itraconazole
1
Immunotherapy, Adoptive
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, B-Cell
×
Ciprofloxacin
×
Clear all
NCT01279252
2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2
Completed
71 enrolled